PAVmed Inc. (PAVM) earnings
PAVM earnings moved a median of +0.71% by the close. Quarterly and annual PAVM reports and results, each read against the price at its own news timestamp. Back to the PAVM overview →
21 measured PAVM earnings events.
Where these PAVM earnings landedvs 19 measured PAVM earnings reactions
| Middle 50% of PAVM earnings reactions | -5.07% to +7.05% |
|---|---|
| Median reaction (to close) | +0.71% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 PAVM earnings events with a measured close landed between -5.07% and +7.05%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results | Press release | +2.55% | +10.64% | |
| Form 10-Q PAVmed Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.55% | +10.64% | |
| PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026 | Press release | — | -1.39% | |
| PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Press release | +0.00% | +2.19% | |
| Form 10-Q PAVmed Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.19% | |
| PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 | Press release | — | +0.71% | |
| Form 10-K PAVmed Inc. For: Dec 31 | SEC filing · Form 10-K | +1.85% | +11.49% | |
| PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results | Press release | -1.84% | — | |
| Form 10-Q PAVmed Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.84% | — | |
| PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results | Press release | -0.72% | -3.25% | |
| Form 10-Q PAVmed Inc. For: Mar 31 | SEC filing · Form 10-Q | -15.58% | -18.20% | |
| PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results | Press release | -15.58% | -18.20% | |
| Form 10-K PAVmed Inc. For: Dec 31 | SEC filing · Form 10-K | -1.25% | -5.06% | |
| Form 10-Q PAVmed Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +6.86% | |
| PAVmed Provides Business Update and Third Quarter 2024 Financial Results | Press release | +0.00% | +6.86% | |
| PAVmed Provides Business Update and Second Quarter 2024 Financial Results | Press release | -5.88% | -12.94% | |
| Form 10-Q PAVmed Inc. For: Jun 30 | SEC filing · Form 10-Q | -5.88% | -12.94% | |
| Form 10-Q PAVmed Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.45% | +7.25% | |
| PAVmed Provides Business Update and First Quarter 2024 Financial Results | Press release | -1.45% | +7.25% | |
| Form 10-K PAVmed Inc. For: Dec 31 | SEC filing · Form 10-K | -3.23% | -5.07% | |
| Form 10-Q PAVmed Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.87% | -4.04% |
Keep exploring
More PAVM: analyst actions → · SEC filings → · PAVM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GENMAB A/S DKK (GNMSF) | 193 | 0.00% | 22% |
| HARBOR DIVERSIFIED INC (HRBR) | 193 | 0.00% | 38% |
| SIENNA BIOPHARMACEUTICALS (SNNA) | 193 | 0.00% | 40% |
| Spero Therapeutics, Inc. (SPRO) | 193 | +0.01% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.